NIC
Northwest Investment Counselors Portfolio holdings
AUM $442M
1-Year Return
29.9%
This Quarter Return
+9.14%
1 Year Return
+29.9%
3 Year Return
+32.42%
5 Year Return
+98.3%
10 Year Return
+217.17%
AUM
$407M
AUM Growth
+$48.7M
(+14%)
Cap. Flow
+$18.9M
Cap. Flow
% of AUM
4.65%
Top 10 Holdings %
Top 10 Hldgs %
35.15%
Holding
501
New
358
Increased
52
Reduced
63
Closed
–
Top Buys
| 1 |
Becton Dickinson
BDX
|
+$1.39M |
| 2 |
Allegion
ALLE
|
+$1.37M |
| 3 |
Microsoft
MSFT
|
+$1.04M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$544K |
| 5 |
Schwab International Equity ETF
SCHF
|
+$444K |
Top Sells
| 1 |
Apple
AAPL
|
+$300K |
| 2 |
AbbVie
ABBV
|
+$176K |
| 3 |
Accenture
ACN
|
+$166K |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$126K |
| 5 |
AutoZone
AZO
|
+$117K |
Sector Composition
| 1 | Technology | 21.82% |
| 2 | Industrials | 13.05% |
| 3 | Consumer Staples | 8.57% |
| 4 | Financials | 8.18% |
| 5 | Healthcare | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
iShares Select Dividend ETF
DVY
$20.4B
| $344K | 0.08% |
2,805
-266
| -9% | -$32.6K |
|
127
iShares Core S&P Small-Cap ETF
IJR
$85.2B
| $343K | 0.08% |
2,996
-133
| -4% | -$15.2K |
|
128
Merck
MRK
$203B
| $318K | 0.08% |
4,145
+11
| +0.3% | +$844 |
|
129
Vanguard High Dividend Yield ETF
VYM
$65.2B
| $307K | 0.08% |
2,736
-121
| -4% | -$13.6K |
|
130
Mastercard
MA
$530B
| $298K | 0.07% |
828
-16
| -2% | -$5.76K |
|
131
iShares MSCI USA Value Factor ETF
VLUE
$7.28B
| $298K | 0.07% |
2,721
-220
| -7% | -$24.1K |
|
132
Integra LifeSciences
IART
$1.16B
| $293K | 0.07% |
4,380
| – | – |
|
133
Newmont
NEM
$86.8B
| $291K | 0.07% |
4,700
+1,000
| +27% | +$61.9K |
|
134
Chevron
CVX
$321B
| $280K | 0.07% |
2,382
-498
| -17% | -$58.5K |
|
135
Eli Lilly
LLY
$686B
| $275K | 0.07% |
995
-20
| -2% | -$5.53K |
|
136
Martin Marietta Materials
MLM
$36.8B
| $265K | 0.07% |
602
| – | – |
|
137
Coca-Cola
KO
$285B
| $263K | 0.06% |
4,446
-100
| -2% | -$5.92K |
|
138
Palo Alto Networks
PANW
$135B
| $254K | 0.06% |
2,742
| – | – |
|
139
Novo Nordisk
NVO
$254B
| $252K | 0.06% |
4,498
| – | – |
|
140
CSX Corp
CSX
$60.5B
| $243K | 0.06% |
+6,465
| New | +$243K |
|
141
Danaher
DHR
$136B
| $236K | 0.06% |
810
| – | – |
|
142
Johnson & Johnson
JNJ
$425B
| $226K | 0.06% |
1,323
| – | – |
|
143
Astec Industries
ASTE
$1.07B
| $219K | 0.05% |
+3,155
| New | +$219K |
|
144
iShares 10-20 Year Treasury Bond ETF
TLH
$11.6B
| $215K | 0.05% |
1,449
| – | – |
|
145
UnitedHealth
UNH
$308B
| $197K | 0.05% |
+392
| New | +$197K |
|
146
iShares MSCI Intl Value Factor ETF
IVLU
$2.64B
| $175K | 0.04% |
6,880
-3,231
| -32% | -$82.2K |
|
147
iShares MSCI USA Min Vol Factor ETF
USMV
$23.2B
| $170K | 0.04% |
+2,098
| New | +$170K |
|
148
Verizon
VZ
$184B
| $169K | 0.04% |
3,250
-584
| -15% | -$30.4K |
|
149
Bank of America
BAC
$375B
| $166K | 0.04% |
+3,725
| New | +$166K |
|
150
Schwab US Mid-Cap ETF
SCHM
$12.2B
| $165K | 0.04% |
+6,159
| New | +$165K |
|